{"nct_id":"NCT00525824","title":"12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe","status":"COMPLETED","status_verified_date":"2011-05","start_date":"2007-08","start_date_type":null,"primary_completion_date":"2008-09","primary_completion_date_type":"ACTUAL","completion_date":"2008-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}